Mid term results of Pemberton pericapsular osteotomy

Mehmet Bülent Balioğlu1, Ali Öner2, Ümit Selçuk Aykut1

  • 1Department of Orthopaedics and Traumatology, Baltalimanı Bone Diseases Research and Training Hospital, Istanbul, Turkey.

Insights

The Pemberton pericapsular osteotomy (PPO) shows comparable mid-term functional and radiological outcomes for treating developmental dysplasia of the hip (DDH) in children aged 16 months to 7 years.

Area of Science:

  • Pediatric Orthopedics
  • Hip Dysplasia Treatment
  • Surgical Outcomes

Background:

  • Developmental dysplasia of the hip (DDH) treatment is age-dependent, with surgical interventions like pelvic osteotomies for older children.
  • Pemberton pericapsular osteotomy (PPO) is a surgical technique used for DDH.
  • This study evaluates the outcomes of PPO in a specific pediatric age group.

Purpose of the Study:

  • To evaluate the radiological and functional outcomes of Pemberton pericapsular osteotomy (PPO) in patients with developmental dysplasia of the hip (DDH).
  • To assess the efficacy of PPO in children aged 16 months to 7 years.

Main Methods:

  • A cohort of 12 patients (14 hips) with DDH underwent PPO between 2001 and 2006.
  • Surgical procedures included PPO alone, PPO with open reduction (OR), or OR + PPO + femoral shortening.
  • Radiological assessments (Acetabular index, Center-edge angle, Tönnis grade, Severin criteria) and clinical evaluations (McKay criteria, Kalamchi-MacEwen criteria) were performed with an average follow-up of 83.35 months.

Main Results:

  • Significant improvement in Acetabular Index (AI) from 41.92° to 19.5° (P < 0.001).
  • Postoperative Center-edge (CE) angle averaged 24.24°.
  • Excellent to good functional outcomes (McKay criteria) were reported in 92.85% of patients.
  • Radiological outcomes according to Severin's classification showed 78.57% of patients as Ia, and 85.71% as type I by Kalamchi-McEven criteria.

Conclusions:

  • Pemberton pericapsular osteotomy (PPO) demonstrates effective mid-term radiological and functional results for treating developmental dysplasia of the hip (DDH).
  • The study supports PPO as a viable surgical option for DDH in children aged 16 months to 7 years.
Abstract

Related Concept Videos